Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.

Dotan I.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):265-74. doi: 10.1586/17474124.1.2.265. Review.

PMID:
19072419
2.

Serologic markers in inflammatory bowel disease.

Bossuyt X.

Clin Chem. 2006 Feb;52(2):171-81. Epub 2005 Dec 8. Review.

3.

[Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].

Desreumaux P, Bourreille A, Colombel JF.

Gastroenterol Clin Biol. 2003 Mar;27(3 Suppl):S81-6. Review. French. No abstract available.

4.

A critical evaluation of serologic markers for inflammatory bowel disease.

Austin GL, Herfarth HH, Sandler RS.

Clin Gastroenterol Hepatol. 2007 May;5(5):545-7. Epub 2007 Apr 12. Review. No abstract available.

PMID:
17433787
5.

Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach.

Targan SR, Karp LC.

Curr Opin Gastroenterol. 2007 Jul;23(4):390-4. Review.

PMID:
17545774
6.

The role of autoantibodies in inflammatory bowel disease.

Herszényi L, Tulassay Z.

Dig Dis. 2012;30(2):201-7. doi: 10.1159/000336702. Epub 2012 Jun 20. Review.

PMID:
22722439
7.

Pathologic features of early inflammatory bowel disease.

Finkelstein SD, Sasatomi E, Regueiro M.

Gastroenterol Clin North Am. 2002 Mar;31(1):133-45. Review.

PMID:
12122728
8.

IBD serological panels: facts and perspectives.

Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M.

Inflamm Bowel Dis. 2007 Dec;13(12):1561-6. Review.

PMID:
17636565
9.

Overview of inflammatory bowel disease in Australia in the last 50 years.

Gibson PR.

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S63-8. doi: 10.1111/j.1440-1746.2009.06073.x. Review.

PMID:
19799701
10.

Inflammatory bowel disease in the elderly.

Picco MF, Cangemi JR.

Gastroenterol Clin North Am. 2009 Sep;38(3):447-62. doi: 10.1016/j.gtc.2009.06.006. Review.

PMID:
19699407
11.

Review of fecal biomarkers in inflammatory bowel disease.

Sutherland AD, Gearry RB, Frizelle FA.

Dis Colon Rectum. 2008 Aug;51(8):1283-91. doi: 10.1007/s10350-008-9310-8. Epub 2008 Jun 10. Review.

PMID:
18543035
12.

Review article: biological activity markers in inflammatory bowel disease.

Desai D, Faubion WA, Sandborn WJ.

Aliment Pharmacol Ther. 2007 Feb 1;25(3):247-55. Epub 2007 Jan 8. Review.

13.

Markers that differentiate early from late IBD.

Huang C, Kugathasan S.

Dig Dis. 2012;30(4):380-2. doi: 10.1159/000338130. Epub 2012 Jul 12. Review.

PMID:
22796800
14.

Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies.

Meier C, Plevy S.

Nat Clin Pract Rheumatol. 2007 Nov;3(11):667-74. Review.

PMID:
17968338
15.

[Measurement of calprotectin in faeces].

Jahnsen J, Røseth AG, Aadland E.

Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):743-5. doi: 10.4045/tidsskr.08.0010. Review. Norwegian.

16.

Inflammatory bowel disease in the geriatric population.

Murad Y, Radi ZA, Murad M, Hall K.

Front Biosci (Elite Ed). 2011 Jun 1;3:945-54. Review.

PMID:
21622103
17.

[Biological markers of activity in chronic inflammatory bowel disease].

Sánchez Lombraña J, Palacio MA, Carbajal C, Vivas S, Pérez R, Rodrigo L.

Rev Esp Enferm Dig. 1997 Nov;89(11):855-8. Review. Spanish. No abstract available.

PMID:
9580203
19.

What is the role of serological markers in IBD? Pediatric and adult data.

Dubinsky M.

Dig Dis. 2009;27(3):259-68. doi: 10.1159/000228559. Epub 2009 Sep 24. Review.

PMID:
19786750
20.

Resistin: another rising biomarker in inflammatory bowel disease?

Karmiris K, Koutroubakis IE.

Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1035-7. Review.

PMID:
17998823

Supplemental Content

Support Center